Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Jul. 31, 2025	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Oct. 01, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from securities purchase agreement equity issuance		$ 50,000	$ 0	$ 0
Equity issued for contingent consideration - ImmPACT Bio USA Inc. acquisition		5,894	0	0
Marketable equity security			30
Impairment of other investments		0	13,001	12,923
Securities Purchase Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from securities purchase agreement equity issuance	$ 50,000
Sale of stock, shares required to purchase by purchaser	$ 50,000
ImmPACT Bio USA Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration, shares issued (in shares)	625,000
Equity issued for contingent consideration - ImmPACT Bio USA Inc. acquisition	$ 5,900
Other Investment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of other investments		$ 0	$ 13,000	12,900
PACT | Other Investment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable equity security					$ 2,900
Impairment of other investments				$ 2,900